Trials / Unknown
UnknownNCT06346561
The Efficacy of Dexmedetomidine Versus Labetalol In Providing Controlled Hypotension In Dacryocystorhinostomy SurgeryA Comparative Randomized Prospective Study
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 50 (estimated)
- Sponsor
- Sohag University · Academic / Other
- Sex
- All
- Age
- 18 Years – 60 Years
- Healthy volunteers
- Accepted
Summary
The most important symptoms of nasolacrimal duct obstruction are excessive tearing and mucoid discharge. The proposed treatment in this regard is dacryocystorhinostomy (DCR) surgery. Therefore, hemostasis is of great significance in performing DCR surgery. In this regard, the reduction of controlled hypotension and the control of hemodynamic responses of the body to stress effectively reduce the bleeding volume during surgery. Hence, there is no enough studies about controlled hypotension in DCR we decided to perform such a comparison between the effect of dexmedetomidine and labetalol in providing controlled hypotension during DCR surgery.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Dexmedetomidine | the reduction of controlled hypotension and the control of hemodynamic responses of the body |
| DRUG | Labetalol | the reduction of controlled hypotension and the control of hemodynamic responses of the body |
Timeline
- Start date
- 2024-03-30
- Primary completion
- 2024-08-30
- Completion
- 2024-08-30
- First posted
- 2024-04-04
- Last updated
- 2024-04-04
Locations
1 site across 1 country: Egypt
Source: ClinicalTrials.gov record NCT06346561. Inclusion in this directory is not an endorsement.